Life Sciences Companies: Sell Now or Sell Later?
By

Life sciences companies in their early stages are in constant need of capital to continue along their path to meeting clinical milestones. Most are pre-revenue and focused on successful completion of Phase I and II clinical trials. And with strong clinical data, these investment prospects are attractive to sources of…Read More

Read More